This bill amends existing Washington statutes (RCW 70.41.480 and RCW 18.64.450) to expand when and how hospitals and health care entities may have practitioners prescribe, dispense, distribute, or deliver “emergency medications” from hospital emergency departments and related settings. It allows prescribers to provide limited amounts of prepackaged emergency medications to patients being discharged from an emergency department when community or outpatient hospital pharmacies are not available, and permits hospitals to authorize practitioners and registered nurses to distribute those prepackaged medications under hospital policies and procedures developed by the hospital pharmacy director in collaboration with medical staff. The bill sets procedural requirements including an approved medication list, pharmacist preparation or supervision, prescribing and distribution criteria, training, documentation of prescriptions, secure storage near the emergency department, and patient counseling by the practitioner before distribution. The bill establishes a default maximum supply of 48 hours for emergency medications dispensed under these provisions, with explicit exceptions when a community or outpatient pharmacy will not be available within 48 hours, when anti-infectives or HIV postexposure prophylaxis drugs or therapies are required, or when manufacturer packaging cannot be altered. It preserves that delivery of a single dose for immediate administration is not subject to these requirements. It also states that these provisions do not limit a practitioner’s authority to distribute opioid overdose reversal medication under RCW 69.41.095 and requires compliance with RCW 70.41.485 when opioid overdose reversal medication is dispensed or distributed in an emergency department. The bill also amends licensing and supervisory requirements for health care entities to purchase, administer, dispense, and deliver legend drugs and controlled substances. It requires health care entities to obtain an annual license from the department to handle controlled substances in accordance with commission rules, and specifies that receipt, administration, dispensing, and delivery of legend drugs or controlled substances by a health care entity must be performed under the supervision or at the direction of a pharmacist. A practitioner may dispense or deliver drugs for a patient’s personal use in an amount not to exceed 72 hours of usage, subject to similar exceptions for pharmacy availability, certain anti-infectives or HIV postexposure prophylaxis, and manufacturer packaging. Practitioners must maintain a valid prescription in the patient’s record before distribution, and nurses or practitioners may only distribute prepackaged emergency medications after a practitioner has counseled the patient. The bill includes definitions for terms such as “emergency medication,” “distribute,” “manufacturer,” “opioid overdose reversal medication,” “practitioner,” and “nurse,” and it references other statutes and commission rules for further definitions and requirements. The excerpt provided shows editing marks and formatting irregularities, relies on other RCW sections and commission rules that are not included here, and does not state an effective date or implementation timeline; calculations for the specified 15-mile distance are not defined in the excerpt.

If enacted, hospitals would be allowed to give patients discharged from emergency departments limited amounts of prepackaged emergency medications when a community or outpatient hospital pharmacy is not available within 15 miles by road. The routine limit would be a 48-hour supply (with specific exceptions for when pharmacies won’t be available within 48 hours, for certain anti-infectives and HIV postexposure prophylaxis, or when manufacturer packaging prevents smaller amounts), and practitioners in health care entities could supply up to 72 hours for a patient’s personal use under similar exceptions. Nurses may only distribute these prepackaged medications after a practitioner has counseled the patient, practitioners must document a valid prescription in the patient record before distribution, and opioid overdose reversal medication is subject to its own statutory treatment. Practically, hospitals, hospital pharmacies, pharmacy directors, and ED clinicians will face new operational duties: creating policies and procedures, pharmacist preparation or supervision of the packaged medications, staff training, secure storage of medications near the ED, documentation and counseling steps, and obtaining an annual license to handle controlled substances where required. These changes are likely to increase administrative work, pharmacist and staff time, and licensing costs, and raise compliance and diversion-management risks; the bill excerpt does not provide an effective date, details on calculating the 15‑mile distance, or the full text of related RCW and commission rules that would affect implementation.